β-cell adaptation and decompensation during the progression of diabetes

Diabetes

Volumn 50, Issue SUPPL. 1, 2001, Pages

  Weir, Gordon C ^a   Laybutt, David Ross ^b   Kaneto, Hideaki ^b   Bonner Weir, Susan ^b   Sharma, Arun ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LACTATE DEHYDROGENASE; MYC PROTEIN;

ADAPTATION; CELL DIFFERENTIATION; CELL STRUCTURE; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE COURSE; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; HYPERTROPHY; INSULIN RELEASE; INSULIN RESISTANCE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PRIORITY JOURNAL;

EID: 0035130272     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.2007.s154     Document Type: Conference Paper

References (45)

1. Insulin secretion in non-insulin-dependent diabetes mellitus
2. Upregulated hexokinase activity in isolated islets from diabetic 90% panereatectomized rats
3. Increased susceptibility of islets from diabetes-prone Psammomys obesus to the deleterious effects of chronic glucose exposure
4. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT2 and glucose incompetence
5. Failure of β-cell mass compensation for insulin resistance in dexamethasone induced diabetes In female Zucker diabetic fatty (ZDF) rats
6. Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes
7. Transcription factor abnormalities as a cause of beta cell dysfunction in diabetes: A hypothesis
8. Chronic hyperglycemia triggers loss of pancreatic β-cell differentiation in an animal model of diabetes
9. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release
10. Islet secretion in a new experimental model for non-insulin-dependent diabetes
11. Apoptosis contributes to the involution of β-cell mass in the post partum rat pancreas
12. Compensatory growth of pray creatic β-cells in adult rats after short-term glucose infusion
13. Hyperglycemia-induced loss of beta cell differentiation is associated with altered expression of genes involved in lipid metabolism
14. Activation of protective and destructive stress genes accompanies beta cell hypertrophy in hyperglycemic rats
15. Overexpression of lactate dehydrogenase A attenuates glucose-induced insulin secretion in stable MIN-6 beta-cell lines
16. Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells
17. c-Myc target genes involved in cell growth, apoptosis, and metabolism
18. Myc target genes
19. The molecular role of Myc in growth and transformation: Recent discoveries lead to new insights
20. Control of ceil proliferation by Myc
21. A unique glucose-dependent apoptotic pathway induced by c-Myc
22. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NFκB activation
23. Kip1
24. What makes cells grow larger and how do they do it?
25. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
26. Signaling pathways for cardiac hypertrophy and failure
27. A novel role for the cyclin-dependent kinase inhibitor p27(kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy
28. Dynamics of β-cell mass in the growing rat pancreas: Estimation with a simple mathematical model (Perspectives)
29. Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats
30. Action of Myc in vivo: Proliferation and apoptosis
31. β-cell dysfunction induced by chronic hyperglycemia: Current ideas on mechanism of impaired glucose-induced insulin secretion
32. Are the β-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?
33. Fatty acids, lipotoxicity and insulin secretion
34. Increase in insulin response after treatment of overt maturity-onset diabetes ts independent of the mode of treatment
35. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion
36. Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion
37. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat
38. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans
39. Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats: Pathogenic implications for obesity-dependent diabetes
40. The beta-cell dysfunction in 48-hour glucose infused rats is not a consequence of elevated plasma lipid or islet triglyceride levels
41. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation
42. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle
43. Chronic exposure to flee fatty acid reduces pancreatic β-cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation
44. Fatty acids decrease IDX-1 expression in mt pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels
45. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests